Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIP.L Regulatory News (CIP)

  • There is currently no data for CIP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - CIP Merchant Capital Limited

31 Mar 2022 07:30

Form 8.5 (EPT/RI) - CIP Merchant Capital Limited

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CIP Merchant Capital Limited
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Financial Advisor to Corporation Financiere Europeenne S.A. (CFE)
(d) Date dealing undertaken: 30th March 2022
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A” N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary Shares Purchase 285,052 59.75 60
Ordinary Shares Sales 285.052 59.75 60

 

(b) Cash-settled derivative transactions

 

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

 

(ii) Exercise

 

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
 

 

 

Date of disclosure:31st March 2022
Contact name:Rich White
Telephone number:+44 207 597 5462

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
11th Feb 20207:00 amRNSNet Asset Value(s)
4th Feb 20207:00 amRNSNet Asset Value(s)
28th Jan 20207:00 amRNSNet Asset Value(s)
21st Jan 20207:00 amRNSNet Asset Value(s)
14th Jan 20207:00 amRNSNet Asset Value(s)
10th Jan 20205:38 pmRNSHolding(s) in Company
10th Jan 20203:18 pmRNSInvestment in Circassia Pharmaceuticals plc
7th Jan 20207:00 amRNSNet Asset Value(s)
31st Dec 20197:00 amRNSNet Asset Value(s)
24th Dec 20197:00 amRNSNet Asset Value(s)
17th Dec 20197:00 amRNSNet Asset Value(s)
10th Dec 20197:00 amRNSNet Asset Value(s)
3rd Dec 20197:00 amRNSNet Asset Value(s)
26th Nov 20197:00 amRNSNet Asset Value(s)
21st Nov 20193:35 pmRNSHolding(s) in Company
21st Nov 20192:50 pmRNSFurther Investment in Brave Bison Group plc
19th Nov 20197:00 amRNSNet Asset Value(s)
12th Nov 20197:00 amRNSNet Asset Value(s)
5th Nov 20197:00 amRNSNet Asset Value(s)
31st Oct 20191:53 pmRNSNotification of Major Shareholder
29th Oct 20197:00 amRNSNet Asset Value(s)
28th Oct 20199:14 amRNSDirectors' Dealing
22nd Oct 20197:00 amRNSNet Asset Value(s)
21st Oct 20199:50 amRNSDirectors' Dealing
18th Oct 201912:26 pmRNSHolding(s) in Company
15th Oct 20197:00 amRNSNet Asset Value(s)
10th Oct 20193:43 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNet Asset Value(s)
4th Oct 20197:00 amRNSDirectors' Dealing
1st Oct 20197:00 amRNSNet Asset Value(s)
24th Sep 20197:00 amRNSNet Asset Value(s)
17th Sep 20197:00 amRNSNet Asset Value(s)
13th Sep 20194:09 pmRNSForm 8.3 - Proactis Holdings PLC - Update
13th Sep 20193:38 pmRNSHolding(s) in Company
13th Sep 20193:19 pmRNSForm 8.3 - Proactis Holdings PLC
10th Sep 20195:16 pmRNSInterim Result for the Period Ended 30 June 2019
10th Sep 20197:00 amRNSNet Asset Value(s)
3rd Sep 20197:00 amRNSNet Asset Value(s)
28th Aug 20197:00 amRNSNet Asset Value(s)
20th Aug 20197:00 amRNSNet Asset Value(s)
13th Aug 20197:00 amRNSNet Asset Value(s)
6th Aug 201910:46 amRNSHolding(s) in Company
6th Aug 201910:45 amRNSFurther Investment in Brave Bison Group plc
6th Aug 20197:00 amRNSNet Asset Value(s)
30th Jul 20194:18 pmRNSDirector Dealing
30th Jul 20197:01 amRNSForm 8.3 - Proactis Holdings PLC
30th Jul 20197:00 amRNSNet Asset Value(s)
23rd Jul 20197:00 amRNSNet Asset Value(s)
18th Jul 20194:19 pmRNSSixth Investment - Brave Bison Group plc
16th Jul 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.